Personal information provided by you shall only be collected, stored and used by Wellcome to the extent that the law allows. Most commonly we will use it to analyse what Wellcome funds and how we fund it. See our for full details. Wellcome will treat the contents of your report as confidential, as set out in section 9 [Letter to be sent on Organisation’s letterhead] Innovations Operations The Wellcome Trust 215 Euston Road London NW1 2BE By Email to: InnovationsOperations@wellcome.ac.uk [Date] Dear Wellcome [Name of Organisation] Consolidated IP and Commercialisation Report covering the period 1 January [YYYY] to 31 December [YYYY] [Option 1 use if reporting IP creation, IP related transactions, revenue/equity generation – from commercialisation and/or use of previously retained Wellcome revenue Please delete any declarations which do not apply]. Please find attached our report to Wellcome for the period above. This report comprises the following appendices: [delete as appropriate] Consolidated IP and Commercialisation report Revenue and Equity Sharing Agreement Revenue Retention Request Declarations: [the first declaration should be given in every case, for the other three please select and include those that apply] This is a complete and accurate report of [Named organisation’s] activities relating to the creation, management and commercialisation of Wellcome-funded IP during the period covered. [We to the revenue and equity sharing terms and conditions set out in Appendix 2 in connection with each commercialisation agreement entered into relating to Wellcome-funded IP during this period, save where bespoke arrangements have been agreed separately with Wellcome’s Innovations Team.] [I confirm that all financial information and revenue & equity calculations contained in this report are complete and accurate.]
Personal information provided by you shall only be collected, stored and used by Wellcome to the extent that the law allows. Most commonly we will use it to analyse what Wellcome funds and how we fund it. See our for full details. Wellcome will treat the contents of your report as confidential, as set out in section 9 [Letter to be sent on Organisation’s letterhead] Innovations Operations The Wellcome Trust 215 Euston Road London NW1 2BE By Email to: InnovationsOperations@wellcome.ac.uk [Date] Dear Wellcome [Name of Organisation] Consolidated IP and Commercialisation Report covering the period 1 January [YYYY] to 31 December [YYYY] [Option 1 – use if reporting IP creation, IP related transactions, revenue/equity generation from commercialisation and/or use of previously retained Wellcome revenue Please delete any declarations which do not apply]. Please find attached our report to Wellcome for the period above. This report comprises the following appendices: [delete as appropriate] Consolidated IP and Commercialisation report Revenue and Equity Sharing Agreement Revenue Retention Request Declarations: [the first declaration should be given in every case, for the other three please select and include those that apply] This is a complete and accurate report of [Named organisation’s] activities relating to the creation, management and commercialisation of Wellcome-funded IP during the period covered. [We to the revenue and equity sharing terms and conditions set out in Appendix 2 in connection with each commercialisation agreement entered into relating to Wellcome-funded IP during this period, save where bespoke arrangements have been agreed separately with Wellcome’s Innovations Team.] [I confirm that all financial information and revenue & equity calculations contained in this report are complete and accurate.]
consolidated-ip-and-commercialisation-report.docx